𝔖 Bobbio Scriptorium

✦ LIBER ✦

Mometasone approved in US for asthma in kids aged 4-11 years

Book ID: 120845593
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2008
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200816240-00066

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to Once-Daily Therapy With Inha

Response to Once-Daily Therapy With Inhaled Mometasone Furoate in Children Aged 4-11 Years With Persistent Asthma

✍ Noonan, M.; Weinstein, S.F.; Berger, W.E.; Staudinger, H. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 43 KB

FDA Approves Nexium for Use in Children

FDA Approves Nexium for Use in Children Ages 1–11 Years

✍ Les Lang 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Effect of Inhaled Mometasone Furoate on

Effect of Inhaled Mometasone Furoate on the Use of Rescue Medication in Children Aged 4-11 Years With Mild to Moderate Persistent Asthma

✍ Berger, W.E.; Noonan, M.; Weinstein, S.F.; Staudinger, H. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Fluticasone propionate HFA improves asth

Fluticasone propionate HFA improves asthma control in children aged 4 to 11 years with asthma*1

✍ LEVY, A 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 26 KB

Population pharmacokinetics of (R)-albut

Population pharmacokinetics of (R)-albuterol and (S)-albuterol in pediatric patients aged 4–11 years with asthma

✍ Gary Maier; Christopher Rubino; Roger Hsu; Thaddeus Grasela; Rudolf A. Baumgartn 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 323 KB

Omalizumab for the Treatment of Severe P

Omalizumab for the Treatment of Severe Persistent Allergic Asthma in Children Aged 6–11 Years

✍ Burch, Jane; Griffin, Susan; McKenna, Claire; Walker, Simon; Paton, James; Wrigh 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 213 KB